Elin K. Esbjorner
Goeteborg, O 41296, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Fragmentation-Induced Disassembly and Reaggregation of α-Synuclein Amyloid Fibrils.
Journal: ACS chemical neuroscience
Published: May 20, 2026
Comparative biodegradation of functionalized graphene oxide nanosheets by myeloperoxidase and neutrophil extracellular traps.
Journal: Frontiers in bioengineering and biotechnology
Published: January 27, 2026
Ganglioside GM1 slows down Aβ(1-42) aggregation by a primary nucleation inhibitory mechanism that is modulated by sphingomyelin and cholesterol.
Journal: Communications chemistry
Published: July 14, 2025
Advanced peptide nanoparticles enable robust and efficient delivery of gene editors across cell types.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: March 25, 2025
Glycosylation-driven interactions of nanoparticles with the extracellular matrix: Implications for inflammation and drug delivery.
Journal: Biomaterials advances
Published: October 23, 2024
Engineering of extracellular vesicles for efficient intracellular delivery of multimodal therapeutics including genome editors.
Journal: Nature communications
Published: June 12, 2024
Extracellular Vesicles Slow Down Aβ(1-42) Aggregation by Interfering with the Amyloid Fibril Elongation Step.
Journal: ACS chemical neuroscience
Published: February 26, 2024
The inhibition of fibril formation of lysozyme by sucrose and trehalose.
Journal: RSC advances
Published: February 15, 2024
Probing physical properties of single amyloid fibrils using nanofluidic channels.
Journal: Nanoscale
Published: November 13, 2023
Monovalent cations have different effects on the assembly kinetics and morphology of α-synuclein amyloid fibrils.
Journal: Biochemical and biophysical research communications
Published: August 07, 2023
Ginsenoside Rg3 Reduces the Toxicity of Graphene Oxide Used for pH-Responsive Delivery of Doxorubicin to Liver and Breast Cancer Cells.
Journal: Pharmaceutics
Published: December 16, 2022
Last Updated: 09/26/2026